Cargando…
Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (https://doi.org/10.1093/braincomms/fcad221).
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507743/ https://www.ncbi.nlm.nih.gov/pubmed/37731901 http://dx.doi.org/10.1093/braincomms/fcad235 |